
Kotak MNC Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Updated: 18 Sept 2026 • 3:31 pm
Posted by:

Kotak MNC Fund Direct Growth Plan currently has a NAV of ₹12.606 as of 17 September 2026 and an AUM of ₹2,309 Cr. Its 1-year, 3-year and 5-year returns are 15.67%, 0% and 0% respectively, and the scheme sits in the High Risk bucket. In our view, the fund is still at an early stage as a listed product, so the limited return history matters as much as the current snapshot.
For investors, the key question is whether the portfolio’s multinational-leaning stock selection can justify the risk. The fund has outpaced the benchmark over 1 year, but the shorter history means the longer-term return picture is still developing.
Quick facts
| Particular | Details |
|---|---|
| NAV | ₹12.606 as of 17 Sep 2026 |
| AUM | ₹2,309 Cr |
| Expense Ratio | 0.58% |
| Launch Date | 28 Oct 2024 |
| Min SIP | ₹100 |
| Risk Category | High Risk |
| Benchmark | Nifty 50 |
| Fund Category | Equity |
| Exit Load | 0.50% on or before 90D, Nil after 90D |
| Fund Managers | Harsha Upadhyaya, Dhananjay Tikariha, Abhishek Bisen |
The fund is managed by Harsha Upadhyaya, Dhananjay Tikariha and Abhishek Bisen.
Source data date: as of 17 Sep 2026
Performance
| Period | Fund return | Benchmark return |
|---|---|---|
| 1M | -3.6% | -3.66% |
| 3M | 0.06% | -3.71% |
| 1Y | 15.67% | -7.13% |
| 3Y | Data not available | Data not available |
| 5Y | Data not available | Data not available |
The fund has been noticeably steadier over the most recent quarter than over the latest month. The 1-month decline was modestly worse than the benchmark, while the 3-month figure turned slightly positive even as the benchmark stayed negative. That tells us the fund has handled the recent stretch better than the index, but not without short-term swings.
On a 1-year view, the gap is much clearer. The fund’s 15.67% return stands well ahead of the benchmark’s -7.13%, which points to a strong relative showing over the period available to us. Even so, the short record means there is no 3-year or 5-year track record yet for a fuller cycle-based reading.
The provided daily path also suggests a pattern of recovery after weaker patches rather than a straight-line rise. That matters for investors because the fund’s return profile has not been smooth, and the High Risk tag is consistent with that kind of movement. Our view is that the fund has shown encouraging momentum, but the history is still too short to treat the 1-year outcome as a settled long-run pattern.
Source data date: as of 17 Sep 2026
Should you BUY or HOLD Kotak MNC?
A fund's past returns alone don't tell you whether you should buy it today or continue holding it.
The right decision depends on factors such as your current allocation, purchase price, risk profile, investment horizon and the role this fund plays in your overall portfolio.
Already holding Kotak MNC? Thinking of investing now?
Peer comparison
| Fund | 1Y return | 3Y return | 5Y return |
|---|---|---|---|
| Kotak MNC Fund Direct Growth Plan | 15.67% | Data not available | Data not available |
| ICICI Pru Strategic Metal and Energy Equity FoF Direct Growth Plan | 69.8% | 36.32% | Data not available |
| HDFC Pharma and Healthcare Fund Direct Growth Plan | 25.31% | Data not available | Data not available |
| Kotak Healthcare Fund Direct Growth Plan | 25.27% | Data not available | Data not available |
| Motilal Oswal Active Momentum Fund Direct Growth Plan | 24.51% | Data not available | Data not available |
| PGIM India Healthcare Fund Direct Growth Plan | 22.75% | Data not available | Data not available |
This assessment is prepared by Uniapps Investment Adviser Pvt. Ltd. under SEBI Registered Investment Adviser registration INA000017639.
Against the available 1-year peer figures, the fund trails several sector- and theme-focused alternatives on raw return, especially ICICI Pru Strategic Metal and Energy Equity FoF Direct Growth Plan and the healthcare names. That said, the comparison is not apples-to-apples in a strict sense because the peer set spans different themes, and this fund’s mandate is more diversified. In the shorter windows, its recent return is better than the benchmark and therefore shows a more resilient near-term profile than the index. The lack of 3-year and 5-year history for the fund also means the longer-term comparison is incomplete.
Source data date: as of 17 Sep 2026
Want to know more? Log in to Univest for more mutual fund insights.
Portfolio: where your money goes
| Holding | Sector | Weight |
|---|---|---|
| Maruti Suzuki India Limited | Automobile & Ancillaries | 4.99% |
| Mtar Technologies Limited | Capital Goods | 4.27% |
| Hindustan Unilever Ltd. | FMCG | 4.26% |
| Ami Organics Ltd | Healthcare | 4.11% |
| Azad Engineering Ltd | Capital Goods | 4.09% |
| Oracle Financial Services Software Ltd | IT | 3.8% |
| Britannia Industries Ltd. | FMCG | 3.75% |
| Nestle India Ltd. | FMCG | 3.56% |
| Ge Vernova T&D India Limited | Capital Goods | 3.47% |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 3.44% |
The largest holding, Maruti Suzuki India Limited, sits at 4.99%, so no single position dominates the visible portfolio. The tenth holding is 3.44%, which means the drop from the top holding to the tenth is fairly modest rather than sharp. That spread suggests the fund may be building exposure through a cluster of mid-sized positions instead of leaning on one or two outsized bets.
The top 10 holdings together account for approximately 39.74% of the portfolio, while 43 holdings are disclosed in total. That combination points to a portfolio that is reasonably spread out, but not so broad that the leading names lose importance. In practical terms, the biggest holdings are still likely to have greater influence on returns, yet the long tail may help keep single-stock dependence in check.
Because the disclosed holdings extend beyond the visible top 10, the fund still has enough breadth to soften concentration at the top. At the same time, the weights in the leading names remain close enough that performance may depend on how several holdings behave together rather than on one clear anchor position.
To see all holdings, visit the Kotak MNC Fund Direct Growth Plan page
Source data date: as of 17 Sep 2026
Who should invest
This fund suits investors who are comfortable with High Risk equity exposure and who can stay invested long enough for the portfolio to play out over a full cycle. The short history shows a strong 1-year outcome, but the lack of a longer public return record means the experience is still developing. Investors who can tolerate uneven short-term moves and who want an equity fund with a somewhat distinct stock-selection style may find the setup relevant.
The main trade-off is simple: the fund has shown better recent behaviour than the benchmark, but the path has not been smooth and the long-term track record is not yet available. That makes it more suitable for investors who can accept variability in exchange for the possibility of differentiated equity exposure. It is less suited to anyone who needs stable, predictable month-to-month outcomes.
Tax and exit load
| Holding period | Tax rate | Description |
|---|---|---|
| Units held less than 1 year | 20% | Short-term capital gains tax |
| Units held more than 1 year | 12.5% | Long-term capital gains tax |
Exit load: 0.50% if units are sold on or before 90 days; nil after 90 days.
Source data date: as of 17 Sep 2026
Frequently asked questions
What is the current NAV of Kotak MNC Fund Direct Growth Plan?
The current NAV is ₹12.606 as of 17 September 2026.
What are the fund’s 1-year, 3-year and 5-year returns?
The fund’s 1-year return is 15.67%, while its 3-year and 5-year returns are Data not available because the track record is still too short for those periods.
How has the fund done against the benchmark?
It has done better than the benchmark over 1 year, with 15.67% versus -7.13%. Over 3 months, it is also slightly positive while the benchmark is negative.
How does it compare with the peer funds listed here?
Its 1-year return is lower than several of the peer funds shown, especially the more thematic healthcare and metals-focused options. The fund’s short-term profile is still respectable, but the peer set shows stronger raw 1-year numbers in several cases.
What is the minimum SIP amount?
The minimum SIP amount is ₹100.
What is the risk category and who manages the fund?
The fund is in the High Risk category. It is managed by Harsha Upadhyaya, Dhananjay Tikariha and Abhishek Bisen.
Bottom line
Kotak MNC Fund Direct Growth Plan has shown better recent performance than the benchmark, but its public return history is still short, so the longer-term picture is not yet fully formed. In the peer set shown, several funds post stronger 1-year numbers, while this fund stands out more for its diversified MNC-style portfolio and balanced top-holding weights. The risk level is High Risk, and the fund appears best suited to investors who can handle volatility and want an equity allocation with a reasonably spread top portfolio rather than heavy concentration in one holding.
Published on 18 September 2026 at 3:29 PM IST
Explore mutual funds with Univest
Review mutual fund data, compare performance and explore fund insights on Univest.
RIA disclosure
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully before investing. This review is prepared by Uniapps Investment Adviser Pvt. Ltd. (earlier known as Uniapps Global Research Pvt. Ltd.) under SEBI Registered Investment Adviser registration INA000017639 for general informational purposes and is not personalized investment advice.
Recent Articles

Mirae Asset Liquid Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

Motilal Oswal Nifty MidSmall Financial Services Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

Mirae Asset Nifty Total Market Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026

Tata Large & Mid Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
18 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Mirae Asset Liquid Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Motilal Oswal Nifty MidSmall Financial Services Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Mirae Asset Nifty Total Market Index Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Tata Large & Mid Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?
Edelweiss Large & Mid Cap Fund Direct Growth Review 2026: NAV, Returns, Portfolio & Should You Invest?

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





